All data are based on the daily closing price as of July 11, 2025
d

Daewoong

003090.KO
19.97 USD
-0.37
-1.82%

Overview

Last close
19.97 usd
Market cap
816.58M usd
52 week high
20.50 usd
52 week low
10.85 usd
Target price
20.37 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.5685
Price/Book Value
1.1271
Enterprise Value
1.16B usd
EV/Revenue
0.8049
EV/EBITDA
8.1383

Key financials

Revenue TTM
1.44B usd
Gross Profit TTM
779.57M usd
EBITDA TTM
256.21M usd
Earnings per Share
N/A usd
Dividend
0.15 usd
Total assets
1.87B usd
Net debt
N/A usd

About

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South Korea.
  • Symbol
    003090.KO
  • Exchange
    KO
  • Isin
    KR7003090008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Yeong-Hwan Yoon
  • Headquarter
    Seongnam
  • Web site
    https://www.daewoongholdings.com

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top